From Financial Modeling Prep: 2025-05-01 11:00:00

Baxter International Inc. (NYSE:BAX) excels in the medtech industry with innovative medical devices. Q1 2025 saw an EPS of $0.62, beating estimates, and revenue of $2.63 billion. Debt-to-equity ratio is 1.93, current ratio at 1.36, showcasing financial stability amidst challenges. Enterprise value ratios indicate strong valuation relative to sales and cash flow.



Read more at Financial Modeling Prep:: Baxter International Inc. (NYSE:BAX) Surpasses Wal…